The microbiome is an exciting area of research for diabetes management. What do we know and what questions do we still have about the microbiome?
Research
The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.
45 readers recommended
People with diabetes who are also a part of the LGBTQ community face unique challenges when it comes to healthcare, dealing with stigma and body image issues. Shawn Laib...
64 readers recommended
Participating in clinical trials are a way for people with diabetes to be directly involved in the evolution of diabetes care. Julie Heverly shares her experience being...
47 readers recommended
The African Heritage Diet centers around traditional foods and plant-based dishes common in Africa, the Caribbean, South America, and the American South.
87 readers recommended
In a study of children younger than seven, automated insulin delivery (AID) led to greater Time in Range, less Time above Range, and lower A1C levels.
160 readers recommended
In a collaboration between ViaCyte and CRISPR Therapeutics, a new clinical trial is investigating a stem cell therapy that may eventually help millions with type 1...
87 readers recommended
Are you currently taking metformin but not meeting your A1C goals? Join a study looking to compare Rybelsus (oral semaglutide) with other oral diabetes drugs to see how...
81 readers recommended
A new study from Stanford has found that early access to diabetes technology might lead to better health outcomes. Navigating your child’s type 1 diagnosis can be...
37 readers recommended
Five percent of people with type 2 diabetes could achieve remission, research says. In recent years, virtual clinics, coaching, and mobile apps have made achieving...
71 readers recommended
As scientific researchers continue to make strides toward a cure for type 1 diabetes, diaTribe sat down with Sean Kramer, the CEO of the Diabetes Research Institute...
89 readers recommended
For relatives of people with type 1 diabetes (T1D), about 5% have certain antibodies associated with causing T1D. By joining this clinical trial, you or your relatives...
42 readers recommended
Early trial results found that SGLT-2 inhibitor Farxiga is highly effective for preventing and treating kidney disease in people with or without type 2 diabetes
45 readers recommended
The diaTribe team covers the latest in diabetes technology from the 14th annual ATTD 2021 international conference (set virtually this year). Here are our top highlights...
91 readers recommended
Drug company Lilly released important results showing that the new therapy may be extremely effective for people with type 2 diabetes. Across three clinical trials,...
40 readers recommended
T1D Exchange Registry data reveals only 17% of youth and 21% of adults are meeting A1C goals, even though more are on pumps and CGM
49 readers recommended
A summary of the landmark trials that show that careful blood glucose management can lower the risk of long-term health complications in people with type 1 or type 2...
67 readers recommended
More people with diabetes are taking drugs like Jardiance and Farxiga, originally developed to lower glucose in people with type 2 diabetes, because the latest data...
60 readers recommended
Steglatro (ertugliflozin) approved on its own and as part of two different combination therapies. Launch in early 2018.
47 readers recommended
How can you prevent or slow the progression of diabetic neuropathy with a continuous glucose monitor (CGM)? Research shows that higher Time in Range (TIR) is associated...
59 readers recommended
Exciting new developments in diabetes research show that increasing your Time in Range can lower your risk of developing heart complications.